UBS Group’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.76M | Buy |
209,750
+136,267
| +185% | +$1.79M | ﹤0.01% | 3561 |
|
|
2025
Q1 | $1.06M | Sell |
73,483
-996,726
| -93% | -$14.3M | ﹤0.01% | 4162 |
|
|
2024
Q4 | $17.9M | Buy |
1,070,209
+1,065,202
| +21,274% | +$17.8M | ﹤0.01% | 1851 |
|
|
2024
Q3 | $80.1K | Buy |
5,007
+2,198
| +78% | +$35.1K | ﹤0.01% | 5316 |
|
|
2024
Q2 | $25.4K | Buy |
2,809
+931
| +50% | +$8.41K | ﹤0.01% | 5999 |
|
|
2024
Q1 | $21.2K | Buy |
1,878
+295
| +19% | +$3.33K | ﹤0.01% | 5736 |
|
|
2023
Q4 | $12.6K | Sell |
1,583
-1,053
| -40% | -$8.38K | ﹤0.01% | 6136 |
|
|
2023
Q3 | $17.1K | Buy |
2,636
+518
| +24% | +$3.35K | ﹤0.01% | 5750 |
|
|
2023
Q2 | $13.1K | Sell |
2,118
-3,045
| -59% | -$18.8K | ﹤0.01% | 5973 |
|
|
2023
Q1 | $19.9K | Buy |
5,163
+2,577
| +100% | +$9.92K | ﹤0.01% | 5994 |
|
|
2022
Q4 | $8.02K | Buy |
2,586
+1,028
| +66% | +$3.19K | ﹤0.01% | 7636 |
|
|
2022
Q3 | $6K | Buy |
+1,558
| New | +$6K | ﹤0.01% | 7906 |
|
|
2022
Q1 | – | Sell |
-496
| Closed | -$6K | – | 9208 |
|
|
2021
Q4 | $6K | Buy |
496
+275
| +124% | +$3.33K | ﹤0.01% | 8133 |
|
|
2021
Q3 | $4K | Sell |
221
-457
| -67% | -$8.27K | ﹤0.01% | 7479 |
|
|
2021
Q2 | $15K | Buy |
+678
| New | +$15K | ﹤0.01% | 6540 |
|